Publications

Centre for Long-Term Resilience

Dr Michael Mahar

CLTR responds to the amendments tabled by the joint SANT and ITRE committees and to the ENVI and JURI opinions. We set out

Dr Cassidy Nelson

In November 2025, the Biosecurity Policy Unit submitted written evidence to the European Union (EU)’s Public Consultation informing the European Biotech Act.

Dr Richard Moulange, Oliver Payne, Dr Paul-Enguerrand Fady & Dr Cassidy Nelson

A framework and four priority programmes to grow the economy and strengthen UK biosecurity in the age of AI.

Dr Paul-Enguerrand Fady, Dr Sarah Winthrope, Dr James Walker and Dr Cassidy Nelson

This blog post and accompanying spreadsheet identify specific, safe knowledge gaps to fill for preparedness without lowering the barriers to creating mirror life.

Dr Paul-Enguerrand Fady, Isaac Heron, Dr Richard Bruns and Dr Cassidy Nelson

Through a cost-benefit analysis, we found that mandatory screening synthetic nucleic acids over 50 base pairs in length bought or sold in the

Dr Paul-Enguerrand Fady and Dr JL Ciccone

Our results suggest that, of the existing antibiotic countermeasures we tested, none were effective against their mirror targets. This implies that these antibiotics

Oliver Payne and Dr Cassidy Nelson

In light of the UK Cabinet Office's two-year update on the BSS Implementation Report, CLTR is providing a narrative response that highlights critical

Dr Paul-Enguerrand Fady

To bolster UK supply chains and increase self-sufficiency of MCM manufacturing, CLTR recommends specific measures be considered by the UK Government.

Dr Paul-Enguerrand Fady

In this submission of evidence, we draw on extensive experience in biosecurity, innovation policy, and international collaboration to identify structural barriers preventing the

Oliver Payne

We submitted detailed recommendations to the Ministry of Defence's Strategic Defence Review 2024, focused on Chemical, Biological, Radiological, and Nuclear (CBRN) threats expected

Dr Cassidy Nelson

We submitted recommendations to the European Commission's consultation on the European Biotech Act, emphasising that security and innovation are complementary objectives.

Dr Paul-Enguerrand Fady

We submitted recommendations to DG HERA's call for evidence on the EU strategy for medical countermeasures against public health threats, drawing on our

Toby Webster, Richard Moulange, Barbara Del Castello, James Walker, Sana Zakaria and Cassidy Nelson

The CLTR-RAND team introduce the first Global Risk Index for AI-enabled Biological Tools: a flexible framework designed to assess these tools based on

Oliver Payne, Cassidy Nelson, Richard Moulange, James Ginns, and Tommy Shaffer Shane

Paul-Enguerrand Fady and Oliver Payne

Rising geoeconomic tensions put cross-border cooperation at risk.

Frankie Di-Nozzi

To better understand public attitudes towards biological threats, The Centre for Long-Term Resilience, in partnership with Public First, recently conducted a nationwide poll

Paul-Enguerrand Fady, Frankie Di-Nozzi, Oliver Payne and Cassidy Nelson

The best time to bolster UK supply chain resilience for medical countermeasures was yesterday. The second best time is now.

Oliver Payne, Paul-Enguerrand Fady, Frankie Di-Nozzi, Sarah Winthrope and Cassidy Nelson

In this report, we propose 6 recommendations that will help grow the UK bioeconomy and build national resilience against future biological events.

Richard Moulange, Tina Wünn and Cassidy Nelson

In this report, we examine the definitions of general-purpose and systemic risk as classified in the EU AI Act and discuss how these

Richard Moulange and Cassidy Nelson

The Centre for Long-Term Resilience recently contributed to the National Institute of Standards and Technology's Safety Considerations for Chemical and/or biological AI models.